APP and Alzheimer disease: In summary, our analyses of 12-month-old mice demonstrate that in the hippocampus of APP/PS1 mice modeling late-stage AD, the protein levels of α2 and α3 subtypes of the GlyR were significantly decreased compared to age-matched WT mice.